규제 업데이트
2026년 8월 24일•1분 읽기
MHRA warns of medication error risk with new Rybelsus tablet
MHRA alerts that the transition to a new Rybelsus® tablet formulation, with different labeled doses but bioequivalent, may cause medication errors and patient harm.
규제 업데이트
2026년 8월 23일•1분 읽기
MHRA Publishes Field Safety Notices for 13‑17 April 2026
The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices issued between 13 and 17 April 2026.
규제 업데이트
2026년 8월 23일•1분 읽기
MHRA Publishes Field Safety Notices for 20‑24 April 2026
The UK Medicines and Healthcare products Regulatory Agency (MHRA) released a list of Field Safety Notices covering 20‑24 April 2026.
규제 업데이트
2026년 8월 23일•1분 읽기
MHRA Publishes Field Safety Notices for 4–8 May 2026
The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices covering the period 4 to 8 May 2026.
규제 업데이트
2026년 8월 23일•1분 읽기
MHRA Publishes Field Safety Notices for 27 April–1 May 2026
The UK Medicines and Healthcare products Regulatory Agency (MHRA) released a list of Field Safety Notices issued between 27 April and 1 May 2026.
규제 업데이트
2026년 8월 23일•1분 읽기
MHRA Publishes Field Safety Notices for 29 June–3 July 2026
The UK Medicines and Healthcare products Regulatory Agency released a list of field safety notices covering drugs and devices from 29 June to 3 July 2026.
규제 업데이트
2026년 8월 23일•1분 읽기
MHRA Issues Field Safety Notices for 3‑7 August 2026
The MHRA released a list of Field Safety Notices covering the period 3 to 7 August 2026.